Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide versus carbamazepine for self-limited epilepsy with centrotemporal spikes in children
IRCT20250203064624N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Benign Rolandic Epilepsy (BECTS) comparing Acetazolamide with Carbamazepine control (2 arms). Primary endpoints: Number of seizure attacks, Probable side effects and 1 more. Started Apr 2025; status: completed.
02
Drugs
acetazolamidecarbamazepine
03
Conditions
Benign Rolandic Epilepsy (BECTS)
Beyond the preview
Go deeper on IRCT20250203064624N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250203064624N1.